Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
          
          https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
        Thromb Haemost 1997; 78(02): 969-970
DOI: 10.1055/s-0038-1657668
   DOI: 10.1055/s-0038-1657668
Letter to the Editor
   Successful Treatment of Lupus Anticoagulant-Hypoprothrombinemia Syndrome Using Intravenous Immunoglobulins
Authors
Further Information
            
               
                  
            
         
      
   Publication History
Received 22  1996
Accepted after revision 26 March 1997
Publication Date:
30 July 2018 (online)
- 
            References
- 1 Arvieux J, Damige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-1125
- 2 Fleck RA, Rapaport SI, Rao VM. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519
- 3 Edson JR, Vogt JM, Hasegawa DK. Abnormal prothrombin crossed-immu- noelectrophoresis in patients with lupus inhibitors. Blood 1984; 64: 807-816
- 4 
            
            Bajaj SP, 
            
            
            Rapaport SI, 
            
            
            Fierer DS, 
            
            
            Herbst KD, 
            
            
            Schwartz DB. 
            
            A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus
            anticoagulant syndrome. Blood 1983; 61: 684-692 
            Reference Ris Wihthout Link
- 5 Peacock NW, Levine SP. The lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med Sciences 1994; 307: 346-349
- 6 Bernini JC, Bushanan GR, Ashcraft J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr 1993; 123: 937-939
- 7 Lee MT, Nardi MA, Hu G, Hadzi-Nesic J, Karpatkin M. Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Am J Hematol 1996; 51: 307-314
- 8 Simel DL, St ClairEW, Adams J, Greenberg CS. Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus antico- agulant-hypoprothrombinemia syndrome. Am J Med 1987; 83: 563-566
- 9 Mouthon L, Hurez V, Kazatchkine M. Mechanisms of action of intravenous immunoglobulins (IglV) in the treatment of autoimmune diseases. An Med Interne 1993; 144: 506-513
- 10 Carreras LO, Perez GN, Martinuzzo ME, Malan-Borel I, Malbran A, Said PB. Partial neutralization of a lupus anticoagulant by human immunoglobulin. Thromb Haemost 1990; 64: 32-37
- 11 Galli M, Cortelazzo S, Barbui T. In vivo efficacy of intravenous immunoglobulins in patients with lupus anticoagulant is not mediated by an anti- idiotypic mechanism. Am J Hematol 1991; 38: 184-188
- 12 Hanley D, Arkel YS, Lynch J, Kamiyama M. Acquired von Willebrand’s syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol 1994; 46: 141-146
- 13 Reznikoff-Etievant M, De LachauxY, Marpeau L, Courouce AM. Intravenous immunoglobulin and hepatitis C transmission in healthy pregnant women. Lancet 1992; 340: 986
 
     
      
    